Sponsered by McGill Univeristy

51st ANNUAL COURSE IN DRUG THERAPY

Virtual Edition

May 6 – 7, 2021

Directeurs de Cours / Course Directors

André Bonnici B.Pharm, MSc / John H. Burgess MD / Paul Lysy MD / Patrizia Zanelli MD

 and MUHC

Goals & Learning Objectives
  • To instill an attitude of critical evaluation of information
  • To evaluate the efficacy, quality & safety of various drugs
  • The evaluation of information published in the literature and delivered by pharmaceutical company detail men
PROGRAMME / Program:
Ce cours sera donné en anglais
This course will be given in English
Some rescheduling of lecture time slots may occur
FRAIS / FEES:
Tarif pour deux jours / Two-day fee: $425
Tarif pour un jour / One-day fee: $250
REMBOURSEMENTS
Remboursement intégral moins 125$ aux annulations écrites reçues avant le 4 avril 2021; moins 50% aux annulations écrites reçues entre le 5 et le 23 avril et aucun remboursement après cette date.
REFUNDS
Full refund less $125.00 administrative fee for a written cancellation received before April 4, 2021, 50% for a written cancellation received between April 5 – 23, 2021 and no refund after that date.
CREDITS
The Continuing Professional Development (CPD) Office from McGill University’s, Faculty of Medicine and Health Sciences, has reviewed the activity: “51st Annual Course in Drug Therapy” and approved it for 13 CPD credits: RCPSC MOC Section 1; CFPC Mainpro+: Group Learning (QC Certification).
CRÉDITS
Le Bureau de développement professionnel continu (DPC) de la Faculté de médecine et des sciences de la santé de l’Université McGill a examiné l’activité: «51e cours annuel de pharmacothérapie» et l’a approuvé pour 13 crédits de DPC: Section 1 du MOC du CRMCC; CFPC Mainpro +: Apprentissage en groupe (certification QC).